Delayed onset of angioedema with angiotensin-converting enzyme inhibitors: case report and review of the literature.

Abstract

The angiotensin-converting enzyme inhibitors have gained widespread application in the management of hypertension and congestive heart failure, and after myocardial infarction. They are generally considered safe drugs, but there are a number of reports of angioedema associated with their use. In general, angioedema occurs within hours to days after initiation of therapy, and only a limited number of reports document a delayed onset. Our patient experienced angioedema after 14 months of therapy with benazepril.

• Authors: N B O'Mara, E M O'Mara Jr
• Journal: Pharmacotherapy (Pharmacotherapy) 1996 Jul-Aug Vol. 16 Issue 4 Pg. 675-9 ISSN: 0277-0008 [Print] United States
• PMID: 8840375 (Publication Type: Case Reports, Journal Article, Review)

Chemical References

• Angiotensin-Converting Enzyme Inhibitors
• Benzazepines
• benazepril

Topics

• Aged
• Angioedema (chemically induced, physiopathology)
• Angiotensin-Converting Enzyme Inhibitors (adverse effects)
• Benzazepines (adverse effects)
• Female
• Humans
• Tongue Diseases (chemically induced, physiopathology)